This is to inform you that the Board of Directors of the Company have at their meeting held today, i.e. 19/06/2025 approved to incorporate a Company as a wholly owned subsidiary in United ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Sudarshan Pharma Industries Ltd approved on 19 June 2025 the incorporation of a wholly-owned subsidiary in the United States, tentatively named 'Sudarshan Industries LLC.' The new entity will focus on manufacturing chemical and pharmaceutical products and trading in general and FMCG goods, helping the company establish a presence in the US market. The subsidiary will be 100% owned by the parent, with no cash consideration or share swap involved since it is a fresh incorporation. Approvals required include RBI clearance under the automatic route of FEMA Overseas Investment Rules, and the incorporation is expected within 6 months.
This is a strategic international expansion move that could open up US market access for the company. However, since it is a greenfield incorporation with no financial details disclosed, the near-term impact on shareholders or stock price is likely limited and depends on future capital infusion and business traction in the US.